Evidence map›Paper›PMID 25962837›Full record

ArticleInflammation research : official journal of the European Histamine Research Society ... [et al.]2015

Transcriptional profiling and targeted proteomics reveals common molecular changes associated with cigarette smoke-induced lung emphysema development in five susceptible mouse strains.

Maciej Cabanski, Brett Fields, Stephanie Boue, Natalia Boukharov, Hector DeLeon, Natalie Dror, Marcel Geertz, Emmanuel Guedj, Anita Iskandar, Ulrike Kogel and 8 more

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Inflammation research : official journal of the European Histamine Research Society ... [et al.], 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Cigarette smoke induction of S100A9 contributes to chronic obstructive pulmonary disease.American journal of physiology. Lung cellular and molecular physiology · 2020
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The multifaceted roles of FOXM1 in pulmonary disease.Cell communication and signaling : CCS · 2019
    Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Advances in understanding COPD.F1000Research · 2016
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 2 countries.

Maciej CabanskiPhilip Morris International Research and Development, Philip Morris Products S.A, Quai Jeanrenaud 5, 2000, Neuchâtel, Switzerland.
Brett Fields
Stephanie Boue
Natalia Boukharov
Hector DeLeon
Natalie Dror
Marcel Geertz
Emmanuel Guedj
Anita Iskandar
Ulrike Kogel
Celine Merg
Michael J Peck
Carine Poussin
Walter K Schlage
Marja Talikka
Nikolai V Ivanov
Julia Hoeng
Manuel C Peitsch
Philip Morris International (Switzerland) · CHSelventa (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMouse models are useful for studying cigarette smoke (CS)-induced chronic pulmonary pathologies such as lung emphysema. To enhance translation of large-scale omics data from mechanistic studies into pathophysiological changes, we have developed computational tools based on reverse causal reasoning (RCR).

objectiveIn the present study we applied a systems biology approach leveraging RCR to identify molecular mechanistic explanations of pathophysiological changes associated with CS-induced lung emphysema in susceptible mice.

methodsThe lung transcriptomes of five mouse models (C57BL/6, ApoE (-/-) , A/J, CD1, and Nrf2 (-/-) ) were analyzed following 5-7 months of CS exposure.

resultsWe predicted 39 molecular changes mostly related to inflammatory processes including known key emphysema drivers such as NF-κB and TLR4 signaling, and increased levels of TNF-α, CSF2, and several interleukins. More importantly, RCR predicted potential molecular mechanisms that are less well-established, including increased transcriptional activity of PU.1, STAT1, C/EBP, FOXM1, YY1, and N-COR, and reduced protein abundance of ITGB6 and CFTR. We corroborated several predictions using targeted proteomic approaches, demonstrating increased abundance of CSF2, C/EBPα, C/EBPβ, PU.1, BRCA1, and STAT1.

conclusionThese systems biology-derived candidate mechanisms common to susceptible mouse models may enhance understanding of CS-induced molecular processes underlying emphysema development in mice and their relevancy for human chronic obstructive pulmonary disease.

Indexed as

NicotianaSmokeAnimalsApolipoproteins EBronchoalveolar Lavage FluidCausalityGene Expression ProfilingInhalation ExposureLungMiceMice, Inbred C57BLMice, Inbred CFTRMice, KnockoutPolymerase Chain ReactionProteomicsPulmonary EmphysemaApolipoproteins ESmoke

Identifiers

PMID25962837
PMCPMC4464601
OpenAlexW1533243960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.